INTANGIBLE ASSETS (Details Narrative)	3 Months Ended
	Mar. 31, 2017 USD ($) Number	Mar. 31, 2016 USD ($)
Finite-Lived Intangible Assets [Line Items]
Amortization expense | $	$ 16,099	$ 11,234
Number of issued patents	17
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life	20 years
Utility Patent Progesterone and Estradiol Products [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	13
Utility Patent TX-004HR [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	2
Utility Patent Pipeline Transdermal Patch Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1
Opera Software Patent [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1